IN THE NEWS

May 7th, 2019

PneumoNIX Medical endorsed by Johns Hopkins Lung Cancer Screening Initiative (Cigarette Restitution Fund)

PneumoNIX Medical was selected to present to Johns Hopkins Hospital, Maryland Department of Commerce and Technology Development Corporation of Maryland about their technology and its ability to increase access to lung cancer screening. The successful large-animal data which was acquired with grant funding has gathered interest from physicians and public health officials about its ability to reduce costs and complications during the lung cancer screening process. Additionally, the results have fast-tracked them for further grant funding. 


April 24-26th

PneumoNIX selected to present at 2019 Angel Capital Association Innovation Showcase

PneumoNIX Medical is 1 of 50 startups nationwide selected to present to the nations top angel investors. The showcase features the most promising startups from life science and technology companies.


March 15th, 2019

PneumoNIX attends ASPIRE investor readiness program through VentureWell

PneumoNIX was selected as 1 of 15 MedTech start-ups to attend VentureWell’s investor readiness program. The program ensures the companies have a solidified go-to-market plan with planned milestones and a comprehensive due diligence deal room package. Furthermore, PneumoNIX secured partnerships to help with product launch and market adoption.


February 1st, 2019

pneumonix awarded Maryland industrial partnerships program phase I grant


November 26th, 2018

pneumonix wins venturewell e-team phase II grant for preventing ptx

Meet PneumoNIX team at the VentureWell E-team workshop in Boston from Jan. 31st - Feb. 2nd


August 2nd, 2018

Pneumonix medical awarded the Cigarette Restitution Fund Grant by State of Maryland


pneumonix wins venturewell e-team phase I grant

June 12th, 2018


July 15th, 2018

Pneumonix awarded the Johns Hopkins tech acceleration fund grant


July 13th, 2018

PNEUMONIX MEDICAL WINS 2nd PLACE AWARD AT THE PRESTIGIOUS NATIONAL BME IDEA DESIGN COMPETITION FOR THEIR NOVEL PreVENT DEVICE

View Article